You have 9 free searches left this month | for more free features.

Condition

Lung Neuroendocrine Neoplasm (1)

Neuroendocrine Tumors (1)

Thymus Neoplasms (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Grupo Espanol de Tumores Neuroendocrinos (1)

Collaborator

ITM Oncologics GmbH (1)

MFAR (1)

Intervention

177lu-edotreotide (1)

everolimus (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

177lu-edotreotide

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting

Neuroendocrine Tumors
+2 more

177Lu-edotreotide
Everolimus

Bourdeaux, France
+24 more

Jun 23, 2023